Cargando…

Upregulation of MDR- and EMT-Related Molecules in Cisplatin-Resistant Human Oral Squamous Cell Carcinoma Cell Lines

Cisplatin is one of the major drugs used in oral cancer treatments, but its usage can be limited by acquired drug resistance. In this study, we established three cisplatin-resistant oral squamous cell carcinoma (OSCC) cell lines and characterized them using cell viability assays, qPCR, Western blott...

Descripción completa

Detalles Bibliográficos
Autores principales:	Choi, Hyeong Sim, Kim, Young-Kyun, Yun, Pil-Young
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6627081/ https://www.ncbi.nlm.nih.gov/pubmed/31234332 http://dx.doi.org/10.3390/ijms20123034

Ejemplares similares

Assessing Gene Expression Related to Cisplatin Resistance in Human Oral Squamous Cell Carcinoma Cell Lines
por: Choi, Hyeong Sim, et al.
Publicado: (2022)

Increased FOXM1 Expression by Cisplatin Inhibits Paclitaxel-Related Apoptosis in Cisplatin-Resistant Human Oral Squamous Cell Carcinoma (OSCC) Cell Lines
por: Choi, Hyeong Sim, et al.
Publicado: (2020)

Cisplatin Plus Cetuximab Inhibits Cisplatin-Resistant Human Oral Squamous Cell Carcinoma Cell Migration and Proliferation but Does Not Enhance Apoptosis
por: Choi, Hyeong Sim, et al.
Publicado: (2021)

The influence of p53 mutation status on the anti-cancer effect of cisplatin in oral squamous cell carcinoma cell lines
por: Jo, Deuk-Won, et al.
Publicado: (2016)

Anticancer effects of CKD-602 (Camtobell(®)) via G2/M phase arrest in oral squamous cell carcinoma cell lines
por: KIM, YOUNG-KYUN, et al.
Publicado: (2015)

Ecdysteroids Sensitize MDR and Non-MDR Cancer Cell Lines to Doxorubicin, Paclitaxel, and Vincristine but Tend to Protect Them from Cisplatin
por: Martins, Ana, et al.
Publicado: (2015)

EGFR Inhibitor Enhances Cisplatin Sensitivity of Oral Squamous Cell Carcinoma Cell Lines
por: Hiraishi, Yukihiro, et al.
Publicado: (2008)

Identification of genes associated with cisplatin resistance in human oral squamous cell carcinoma cell line
por: Zhang, Ping, et al.
Publicado: (2006)

Quercetin Inhibits Cell Survival and Metastatic Ability via the EMT-Mediated Pathway in Oral Squamous Cell Carcinoma
por: Kim, So Ra, et al.
Publicado: (2020)

Downregulation of microRNA-4324 promotes the EMT of esophageal squamous-cell carcinoma cells via upregulating FAK
por: Zhou, Jian, et al.
Publicado: (2019)

Nipped-B-like Protein Sensitizes Esophageal Squamous Cell Carcinoma Cells to Cisplatin via Upregulation of PUMA
por: Zhang, Shengjie, et al.
Publicado: (2020)

Evaluation of apoptotic effect of crocin, cisplatin, and their combination in human oral squamous cell carcinoma cell line HN5
por: Bijani, Fatima, et al.
Publicado: (2021)

Upregulation of long noncoding RNA HOTTIP promotes metastasis of esophageal squamous cell carcinoma via induction of EMT
por: Chen, Xuemei, et al.
Publicado: (2016)

DHFR and MDR1 upregulation is associated with chemoresistance in osteosarcoma stem-like cells
por: Lee, Yu-Hsien, et al.
Publicado: (2017)

TGF-β1-Induced Upregulation of MALAT1 Promotes Kazakh's Esophageal Squamous Cell Carcinoma Invasion by EMT
por: Liu, Qing, et al.
Publicado: (2020)

NSG1 promotes glycolytic metabolism to enhance Esophageal squamous cell carcinoma EMT process by upregulating TGF-β
por: Tu, Mingshu, et al.
Publicado: (2023)

Cepharanthine hydrochloride reverses the mdr1 (P-glycoprotein)-mediated esophageal squamous cell carcinoma cell cisplatin resistance through JNK and p53 signals
por: Zhou, Pengjun, et al.
Publicado: (2017)

A pilot study of camrelizumab with docetaxel and cisplatin for the first line treatment in recurrent/metastatic oral squamous cell carcinoma
por: Ju, Houyu, et al.
Publicado: (2023)

The Differential Metabolic Response of Oral Squamous Cell Carcinoma Cells and Normal Oral Epithelial Cells to Cisplatin Exposure
por: Chen, Xun, et al.
Publicado: (2022)

lncRNA MALAT1 Promotes EMT Process and Cisplatin Resistance of Oral Squamous Cell Carcinoma via PI3K/AKT/m-TOR Signal Pathway
por: Wang, Ran, et al.
Publicado: (2020)

Partial EMT in Squamous Cell Carcinoma: A Snapshot
por: Liao, Chengcheng, et al.
Publicado: (2021)

FOXD1 promotes EMT and cell stemness of oral squamous cell carcinoma by transcriptional activation of SNAI2
por: Chen, Yang, et al.
Publicado: (2021)

Naa10p Enhances Chemosensitivity to Cisplatin in Oral Squamous Cell Carcinoma Cells
por: Sun, Lichun, et al.
Publicado: (2021)

Combinatorial Effect of Cold Atmosphere Plasma (CAP) and the Anticancer Drug Cisplatin on Oral Squamous Cell Cancer Therapy
por: Lee, Chang-Min, et al.
Publicado: (2020)

Correction: Cepharanthine hydrochloride reverses the mdr1 (P-glycoprotein)-mediated esophageal squamous cell carcinoma cell cisplatin resistance through JNK and p53 signals
por: Zhou, Pengjun, et al.
Publicado: (2021)

TGF-β1-Induced Upregulation of MALAT1 Promotes Kazakh's Esophageal Squamous Cell Carcinoma Invasion by EMT: Erratum
por: Liu, Qing, et al.
Publicado: (2022)

Phytochemicals: Potential Lead Molecules for MDR Reversal
por: Tinoush, Boshra, et al.
Publicado: (2020)

Osteopontin Involves Cisplatin Resistance and Poor Prognosis in Oral Squamous Cell Carcinoma
por: Luo, Sheng-Dean, et al.
Publicado: (2015)

Overexpression of β-Catenin Induces Cisplatin Resistance in Oral Squamous Cell Carcinoma
por: Li, Long, et al.
Publicado: (2016)

The Molecular Basis and Therapeutic Aspects of Cisplatin Resistance in Oral Squamous Cell Carcinoma
por: Cheng, Yali, et al.
Publicado: (2021)

DDB2 regulates Epithelial-to-Mesenchymal Transition (EMT) in Oral/Head and Neck Squamous Cell Carcinoma
por: Bommi, Prashant V., et al.
Publicado: (2018)

Overexpression of Mena is associated with tumor progression and poor prognosis in oral squamous cell carcinoma via EMT
por: Na, Sijia, et al.
Publicado: (2022)

DJ-1 Is Upregulated in Oral Squamous Cell Carcinoma and Promotes Oral Cancer Cell Proliferation and Invasion
por: Xu, Shuaimei, et al.
Publicado: (2016)

Cisplatin-Resistance in Oral Squamous Cell Carcinoma: Regulation by Tumor Cell-Derived Extracellular Vesicles
por: Khoo, Xin-Hui, et al.
Publicado: (2019)

Gimeracil enhances the antitumor effect of cisplatin in oral squamous cell carcinoma cells in vitro and in vivo
por: Harada, Koji, et al.
Publicado: (2017)

The effect of sodium butyrate and cisplatin on expression of EMT markers
por: Mrkvicova, Alena, et al.
Publicado: (2019)

Association of the Epithelial–Mesenchymal Transition (EMT) with Cisplatin Resistance
por: Ashrafizadeh, Milad, et al.
Publicado: (2020)

TRIM11 Upregulation Contributes to Proliferation, Invasion, and EMT of Hepatocellular Carcinoma Cells
por: Zhang, Zewei, et al.
Publicado: (2017)

Astrocyte elevated gene-1 promotes tumour growth and invasion by inducing EMT in oral squamous cell carcinoma
por: Wang, Yan, et al.
Publicado: (2017)

HOXC10 promotes migration and invasion via the WNT-EMT signaling pathway in oral squamous cell carcinoma
por: Dai, Bo-Wen, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_l7gakdautm35sgbmu4qf0nc7ti